Articulation Disorder
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluating the Efficacy of Opti-Speech for Speech Treatment (NCT02705326) | Vulintus, Inc. | 2016-01-01 |
Track Articulation Disorder automatically
Every clearance here is in the API, with alerts when new ones post.